celecoxib has been researched along with aee 788 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Chakraborty, C; Chaudhury, K; Das, S; Krishnan, MM; Mandal, M; Venkatesan, P | 1 |
| Bhutia, SK; Chaudhury, K; Das, SK; Dash, R; Fisher, PB; Mandal, M; Sarkar, D; Singh, AK; Venkatesan, P | 1 |
| Aranda, E; Cañas, A; Conde, F; de la Haba-Rodríguez, J; Hernández, V; López-Pedrera, C; López-Sánchez, LM; Peñarando, J; Peralbo, E; Rodríguez-Ariza, A; Valverde, A | 1 |
4 other study(ies) available for celecoxib and aee 788
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Effect of AEE788 and/or Celecoxib on colon cancer cell morphology using advanced microscopic techniques.
Topics: Antineoplastic Agents; Celecoxib; Cell Shape; Colonic Neoplasms; Cytoskeleton; Epithelial Cells; Humans; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Purines; Pyrazoles; Sulfonamides | 2010 |
AEE788 potentiates celecoxib-induced growth inhibition and apoptosis in human colon cancer cells.
Topics: Actins; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Celecoxib; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chickens; Colonic Neoplasms; Cyclooxygenase 2 Inhibitors; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Purines; Pyrazoles; Reactive Oxygen Species; Sulfonamides | 2012 |
Simultaneous inhibition of EGFR/VEGFR and cyclooxygenase-2 targets stemness-related pathways in colorectal cancer cells.
Topics: Apoptosis; Caco-2 Cells; Celecoxib; Cell Cycle; Cell Proliferation; Colorectal Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Progression; Enzyme-Linked Immunosorbent Assay; ErbB Receptors; G1 Phase; Gene Expression Regulation, Neoplastic; Genes, ras; HCT116 Cells; Humans; Microscopy, Confocal; Neoplastic Stem Cells; Neovascularization, Pathologic; Purines; Receptors, Vascular Endothelial Growth Factor; Vascular Endothelial Growth Factor A; Wound Healing | 2015 |